Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0209 | 0.252 | 0.1792 |
Trypanosoma cruzi | sedoheptulose-1,7-bisphosphatase, putative | 0.0247 | 0.314 | 0.2472 |
Trichomonas vaginalis | CAMK family protein kinase | 0.011 | 0.0887 | 0.5 |
Echinococcus granulosus | melanoma receptor tyrosine protein kinase | 0.0352 | 0.4865 | 0.4365 |
Toxoplasma gondii | fructose-bisphospatase II | 0.0664 | 1 | 1 |
Loa Loa (eye worm) | TK/EGFR protein kinase | 0.0655 | 0.9849 | 0.9849 |
Schistosoma mansoni | tyrosine kinase | 0.0655 | 0.9849 | 0.9834 |
Trichomonas vaginalis | CAMK family protein kinase | 0.011 | 0.0887 | 0.5 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.011 | 0.0887 | 0.5 |
Trypanosoma cruzi | fructose-1,6-bisphosphatase, cytosolic, putative | 0.0664 | 1 | 1 |
Echinococcus granulosus | insulin receptor | 0.0209 | 0.252 | 0.1792 |
Schistosoma mansoni | tyrosine kinase | 0.0348 | 0.4804 | 0.4298 |
Echinococcus multilocularis | fructose 1,6 bisphosphatase 1 | 0.0664 | 1 | 1 |
Trypanosoma cruzi | sedoheptulose-1,7-bisphosphatase, putative | 0.0247 | 0.314 | 0.2472 |
Schistosoma mansoni | fructose-16-bisphosphatase-related | 0.0664 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.011 | 0.0887 | 0.5 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0655 | 0.9849 | 0.9834 |
Leishmania major | 0.0664 | 1 | 1 | |
Echinococcus multilocularis | insulin receptor | 0.0209 | 0.252 | 0.1792 |
Trichomonas vaginalis | CAMK family protein kinase | 0.011 | 0.0887 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.011 | 0.0887 | 0.5 |
Loa Loa (eye worm) | fructose-1,6-bisphosphatase | 0.0664 | 1 | 1 |
Echinococcus multilocularis | 0.0203 | 0.2412 | 0.1673 | |
Giardia lamblia | Kinase, PLK | 0.011 | 0.0887 | 0.5 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0352 | 0.4865 | 0.4365 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.011 | 0.0887 | 0.0887 |
Trichomonas vaginalis | CAMK family protein kinase | 0.011 | 0.0887 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0348 | 0.4804 | 0.4298 |
Trypanosoma brucei | fructose-1,6-bisphosphatase | 0.0664 | 1 | 1 |
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.011 | 0.0887 | 0.0887 |
Trichomonas vaginalis | CAMK family protein kinase | 0.011 | 0.0887 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0352 | 0.4865 | 0.4365 |
Echinococcus granulosus | insulin growth factor 1 receptor beta | 0.0209 | 0.252 | 0.1792 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0655 | 0.9849 | 0.9834 |
Loa Loa (eye worm) | TK/INSR protein kinase | 0.0209 | 0.252 | 0.252 |
Schistosoma mansoni | tyrosine kinase | 0.0348 | 0.4804 | 0.4298 |
Brugia malayi | Furin-like cysteine rich region family protein | 0.0655 | 0.9849 | 0.9849 |
Trypanosoma brucei | sedoheptulose-1,7-bisphosphatase | 0.0247 | 0.314 | 0.2472 |
Schistosoma mansoni | tyrosine kinase | 0.0209 | 0.252 | 0.1792 |
Brugia malayi | Protein kinase domain containing protein | 0.0209 | 0.252 | 0.252 |
Trypanosoma cruzi | fructose-1,6-bisphosphatase, cytosolic, putative | 0.0664 | 1 | 1 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.011 | 0.0887 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0352 | 0.4865 | 0.4365 |
Echinococcus granulosus | fructose 16 bisphosphatase 1 | 0.0664 | 1 | 1 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0352 | 0.4865 | 0.4365 |
Schistosoma mansoni | tyrosine kinase | 0.0209 | 0.252 | 0.1792 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 713 uM | Inhibition of fluorescent (GpYEEI) binding to Src protein tryrosine kinase SH2 domain | ChEMBL. | 15261270 |
IC50 (binding) | = 713 uM | Inhibition of fluorescent (GpYEEI) binding to Src protein tryrosine kinase SH2 domain | ChEMBL. | 15261270 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.